New in silico and conventional in vitro approaches to advance HIV drug discovery and design

By Maga Giovanni   Veljkovic Nevena   Crespan Emmanuele   Spadari Silvio   Prljic Jelena   Perovic Vladimir   Glisic Sanja   Veljkovic Veljko  

Expert Opinion on Drug Discovery, Vol. 8, Iss. 1, 2013-01 ,pp. : 83-92

Informa Healthcare

Access to resources Recommend Favorite

Computational Tools for In Silico Fragment-Based Drug Design

By  

Current Topics in Medicinal Chemistry, Vol. 12, Iss. 17, 2012-09 ,pp. : 1935-1943

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutics for filovirus infection: traditional approaches and progress towards in silico drug design

By Shurtleff Amy C   Nguyen Tam L   Kingery David A   Bavari Sina  

Expert Opinion on Drug Discovery, Vol. 7, Iss. 10, 2012-10 ,pp. : 935-954

Informa Healthcare

Access to resources Recommend Favorite

High-throughput and in silico screenings in drug discovery

By Phatak Sharangdhar S   Stephan Clifford C   Cavasotto Claudio N  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 9, 2009-09 ,pp. : 947-959

Informa Healthcare

Access to resources Recommend Favorite

Design and in silico screening of inhibitors of the cholera toxin

By Zhang Guangtao  

Expert Opinion on Drug Discovery, Vol. 4, Iss. 9, 2009-09 ,pp. : 923-938

Informa Healthcare

Access to resources Recommend Favorite